Healthcare provider profile · identity verified

Betty Fields, APRN

Nurse Practitioner · WOODSTOCK, VT · NPI 1952759904

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	525	130
Levothyroxine Sodium	Levothyroxine Sodium	291	68
Losartan Potassium	Losartan Potassium	258	67
Amlodipine Besylate	Amlodipine Besylate	233	68
Hydrochlorothiazide	Hydrochlorothiazide	233	66
Omeprazole	Omeprazole	205	60
Lisinopril	Lisinopril	203	52
Metoprolol Succinate	Metoprolol Succinate	164	44
Eliquis	Apixaban	150	28
Furosemide	Furosemide	111	27
Escitalopram Oxalate	Escitalopram Oxalate	108	25
Metformin Hcl	Metformin Hcl	108	32
Sertraline Hcl	Sertraline Hcl	98	20
Gabapentin	Gabapentin	92	29
Pantoprazole Sodium	Pantoprazole Sodium	91	27
Trazodone Hcl	Trazodone Hcl	87	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	12
Simvastatin	Simvastatin	74	22
Metoprolol Tartrate	Metoprolol Tartrate	68	20
Rosuvastatin Calcium	Rosuvastatin Calcium	63	18
Duloxetine Hcl	Duloxetine Hcl	62	16
Amitriptyline Hcl	Amitriptyline Hcl	60	13
Carvedilol	Carvedilol	58	12
Citalopram Hbr	Citalopram Hydrobromide	51	12
Fluoxetine Hcl	Fluoxetine Hcl	51	13
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	46	22
Bupropion Xl	Bupropion Hcl	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Tramadol Hcl	Tramadol Hcl	42	13
Atenolol	Atenolol	40	11
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Meloxicam	Meloxicam	37	11
Lorazepam	Lorazepam	36	16
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Potassium Chloride	Potassium Chloride	35	12
Celecoxib	Celecoxib	34	suppressed
Glimepiride	Glimepiride	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	13
Alprazolam	Alprazolam	32	suppressed
Lidocaine	Lidocaine	31	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Ozempic	Semaglutide	28	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Glipizide	Glipizide	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Amoxicillin	Amoxicillin	25	14
Prednisone	Prednisone	25	20
Trulicity	Dulaglutide	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	24
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Naproxen	Naproxen	24	14
Olanzapine	Olanzapine	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Methylphenidate Er	Methylphenidate Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Famotidine	Famotidine	21	suppressed
Fluconazole	Fluconazole	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Cephalexin	Cephalexin	20	18
Enalapril Maleate	Enalapril Maleate	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Azithromycin	Azithromycin	18	14
Bupropion Hcl	Bupropion Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	13
Nitroglycerin	Nitroglycerin	18	17
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Finasteride	Finasteride	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error